518 statistical jobs at 261 companies in Newton, MA
2d
Save
Mark Applied
Hide
2d
Statistical Programmer
Boston, Massachusetts, United States
$110k-$165k/yrHybridFull Time
Rhythm PharmaceuticalsNASDAQ: RYTM: Develops precision medicines for rare neuroendocrine and obesity diseases.
3+ YOEMS or equivalent preferred, 3+ years statistical programming experience in pharma/biotech/CRO, strong SAS (including Base SAS, SAS/STAT, SAS/GRAPH, SAS/SQL, SAS/ODS) and CDISC expertise, EM submission experience, strong communication and critical thinking.
Servier: Independent global pharmaceutical group developing innovative treatments for patients.
8+ YOEMasters in statistics/engineering or related field, minimum 8 years statistical programming/biostatistics in pharma, proficient in SAS and CDISC (ADaM/SDTM), strong regulatory knowledge and study management skills.
United States or Atlanta or Austin or Houston or Raleigh or Phoenix or Boston or Minneapolis or Dallas
$90k-$100k/yrRemoteFull Time
LivaNovaNASDAQ: LIVN: Manufactures medical devices for cardiac and neurological therapies.
Bachelor's in a quantitative field, relevant clinical trial/statistical programming experience, strong SAS skills, knowledge of SDTM/ADaM and programming QC, ability to produce validated, well-documented code and collaborate with cross-functional teams.
SAS, SAS Enterprise Guide, R, Python, SQL, Git, CDISC, SDTM, ADaM
Alnylam PharmaceuticalsNASDAQ: ALNY: Develops RNAi therapeutics to treat rare and common diseases.
8+ YOEBachelor's in engineering/IT/computer science,8+ years statistical programming experience with SAS including macro/SAS/SQL/SAS/GRAPH/SAS/STAT,CDISC (SDTM/ADaM),clinical trial reporting and review of DMPs/eCRF specs/SAPs.
Cambridge or Spain or United Kingdom or Netherlands
RemoteFull Time
Cytel: Provides clinical trial design software and biostatistical consulting services.
8+ YOEBachelor's in statistics/CS/math,8+ years SAS clinical trial programming experience,study lead experience,CDISC SDTM/ADaM expertise,QC/validation and submission document experience.
Bristol Myers SquibbNew York Stock Exchange: BMY: Develops and distributes innovative medicines for serious diseases.
10+ YOEMS (10+ yrs) or BS (12+ yrs) industry experience; proven leadership in statistical programming, drug development operational experience, talent attraction/retention, and expertise in clinical trial programming and regulatory standards.
AstraZenecaLondon Stock Exchange: AZN: Global biopharmaceutical developing and manufacturing prescription medicines.
10+ YOE7+ Mgmt10+ years statistical programming experience, 7+ years people/project management, advanced SAS skills, knowledge of CDISC SDTM/ADaM and eCTD submissions, budget and vendor management, leadership and cross-functional collaboration.
King of Prussia or Maidenhead or Waltham or Glattbrugg
$239k-$308k/yrOnsiteFull Time
CSLASX: CSL: Develops and manufactures biopharmaceutical products and vaccines.
10+ YOE5+ MgmtBSc in Computer Science/Math/Statistics or equivalent, 10+ years industry experience in biotech/pharma/CRO, 5+ years supervisory experience preferred, advanced SAS and CDISC knowledge, CRO management experience, strong communication and leadership skills.
BiogenNASDAQ: BIIB: Biogen develops therapies for neurological and neurodegenerative diseases.
2+ YOEBachelor's required (Masters preferred) in statistics/math/CS,2+ years relevant experience,2+ years SAS Base programming (STAT, GRAPH, MACRO),CDISC/submissions experience,UNIX and R familiarity,knowledge of clinical trials and regulatory submissions.
SAS Base, SAS STAT, SAS GRAPH, SAS MACRO, CDISC, define.xml, XPT, UNIX, R, WinNonLin, NONMEM
Bicycle TherapeuticsNASDAQ: BCYC: Developing synthetic peptide medicines for oncology and other diseases.
Expert statistical programming in biotech/pharma, SAS and CDISC (SDTM/ADaM) experience, regulatory submission preparation, CRO/vendor management, leadership and strategic planning for clinical programs.
MapLight TherapeuticsNASDAQ: MPLT: Develops targeted drug therapies for central nervous system disorders.
8+ YOEMaster’s in statistics, computer science or related field; 8+ years statistical programming in pharma/biotech; SAS expert; CDISC SDTM/ADaM; CRO management; FDA/ICH knowledge.
RegeneronNasdaq: REGN: Discovers and manufactures medicines for serious diseases.
10+ YOEAdvanced SAS programming in clinical data, understanding of clinical trial/statistical and regulatory submission requirements, proven project and people leadership, mentoring experience, 10+ years programming experience.
Vertex PharmaceuticalsNASDAQ: VRTX: Develops and sells prescription drugs for serious genetic diseases.
8+ YOEB.S. in a scientific discipline, 8+ years clinical programming experience, proficiency with SAS and CDISC, eCTD submission experience, strong communication and project skills.
AstraZenecaLondon Stock Exchange: AZN: Researches and develops medicines to treat major diseases globally.
10+ YOELead strategic direction of statistical programming; 10+ years in programming strategy; AI/automation; leadership; outsourcing experience; CDISC standards.
AlnylamNasdaq: ALNY: Developing and commercializing RNA interference (RNAi) therapeutics for diseases.
10+ YOE10+ years SAS programming experience in pharma/biotech/CRO, experience leading programming teams, CDISC (SDTM/ADaM) knowledge, proficiency in R and SAS, strong communication and organization.
Kura OncologyNASDAQ: KURA: Develops precision small molecule medicines for cancer treatment.
10+ YOE10+ years clinical programming experience; MS (or BS with additional experience) in quantitative field; advanced SAS skills; CDISC, ICH, GCP, 21 CFR Part 11 knowledge; experience with regulatory submissions; mentoring and vendor management experience.
Zenas BioPharmaNASDAQ: ZBIO: Develops transformative therapies for patients with autoimmune diseases.
7+ YOEMaster's in Biostatistics/CS with 7+ years or Bachelor's with 9+ years; strong SAS and CDISC (SDTM/ADaM) knowledge; regulatory filing and ISS/ISE experience; CRO/vendor management and excellent communication.